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ABSTRACT 
Function of EC27, a Putative Cyclin Encoded by Baculovirus, 
And Composition of the EC27-associated 
Protein Complex. (April 2000) 
Luke James Engelking 
Department of Biochemistry and Biophysics 
Texas ARM University 
Fellows Advisor: Dr. Max D. Summers 
Department of Biochemistry and Biophysics 
Baculovirus encodes a unique protein, EC27, that may be multifunctional cyclin. 
EC27 is a structural component of the virus, has amino acid sequence homology with the 
cyclin fold region of several cellular cyclins, and is part of immunoprecipitated protein 
complexes that have cyclin B and cyclin D-like kinase activities. Baculovirus infection 
apparently alters or overrides at least two checkpoints in the host cell cycle: entry into S- 
phase and progression through G2/M-phase. We speculate abrogation of these cell cycle 
checkpoints is accomplished by the function of virus encoded proteins. EC27 potentially 
interacts with the key regulatory elements of those two cell cycle checkpoints; we know 
that EC27 is present in active complexes that contain cdc2 (G2/M-phase, cyclin B-like 
function) and cdk6 (Gl/S-phase, cyclin D-like function). EC27 is therefore a likely 
suspect as a viral protein involved in host cell cycle manipulation. To understand the 
function of EC27 during infection, we endeavored to identify the proteins that EC27 
interacts with in the cell by western blot analysis of EC27 immunoprecipitates. A yeast 
two-hybrid screen, performed as part of preliminary studies into EC27 function, 
identified another baculovirus structural protein, ORF101, as an EC27-interacting 
protein. We confirmed by immunoprecipitation that that ORF101 can be detected in 
complexes precipitated by EC27 antisera and vice versa. Using antisera that seem to 
discriminate between different molecular weight forms of EC27, we demonstrated EC27 
may form different complexes with distinct compositions. We showed that ORF101 can 
associate with the 35 kilodalton form of EC27 but not with the 27 kilodalton form of 
EC27. To test if EC27 alone can function as a cyclin, we performed a yeast 
complementation assay in Gl-cyclin deficient Saccharomyces cerevisiae. We 
deinonstrated that full-length EC27 cannot rescue the Gl-cyclin deficient phenotype. 
This result can be interpreted in two ways: first, since soine cellular cyclins also fail the 
complementation test, this result may be a false negative; second, this result may 
indicate that the mechanism of EC27's interaction with cdk's is different than cellular 
cyclins. The latter interpretation supports the idea that EC27's functional state may be as 
part of a larger protein complex. 
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INTRODUCTION 
The Biology of Baculoviruses 
Autographa californica nucleopolyhedrovirus (AcMNPV), a genetically complex 
double-stranded DNA virus of the family Baculoviridae that is infectious to a wide range 
of lepidopteran insects, has a long evolutionary history with its host (Miller, 1997). The 
etymology of the tertn baculovirus come from the latin word for staff or rod, "baculum", 
owing to the rod-like shape of the virus particle. 
Baculovirus infection is spread between hosts through the ingestion of viral 
occlusions, or virus particles encapsulated in a protein matrix (see Miller, 1997 for 
review). In the alkaline pH of the insect midgut, viral occlusions dissolve and release 
ODV (occlusion derived virus). ODV infect the columnar cells of the midgut 
epithelium; entry into cells occurs by fusion of the virion envelope and the microvillar 
membrane. The nucleocapsid then moves into the nucleus and viral DNA replication 
begins. At approximately 10-12 hours post infection, BV (budded virus) is produced. 
This type of viral progeny causes secondary infection in other tissues of the host. 
Budded virus has a different structure than ODV: its envelope is derived from the 
plasma membrane as it buds from the host cell while ODV's membrane is derived from 
the nuclear membrane (Braunagel et al. , 1994). The principal form of progeny virus in 
the midgut is BV; tissues that are infected secondarily, such as the fat body, produce 
enormous titers of ODV. In total, the infection process occurs over 5-10 days and ends 
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in wilting or liquefaction of the host insect. ODV are released into the environment, 
protected inside polyhedra (the protein crystals which encapsulate ODV, made of the 
protein polyhedrin), and await a host. 
AcMNPV infection potentially influences at least two cell cycle checkpoints. 
During priinary infection of the migut, the virus must hastily produce BV or risk being 
fended off by the host. The migut epithelial cell is terminally differentiated, or in the GO 
cell cycle phase. Therefore, the midgut cell's DNA replication machinery is inactive. To 
successfully infect the insect, the virus must have a mechanism to progress the cell into 
an S-phase like environment so that this first round of viral DNA replication and 
concomitant BV production can occur. 
This promotion of S-phase is seen in the infection of in vitro SF9 cell culture. At 
approximately 8-10 hours post infection, an enrichment in the proportion of cells in S- 
phase is observed and is accompanied by an increase in viral DNA replication 
(Braunagel et al. , 1998). Abrogation of a second checkpoint is also seen in vitro: 
AcMNPV infection of SF9 cells results in a G2/M phase arrest of approximately 85'/o of 
the cell population at 18-24 hours post infection. Viral DNA synthesis continues beyond 
this point independently of cellular DNA synthesis and "out of phase" since DNA 
replication occurs in S-phase (Braunagel et al. , 1998). 
If a cell culture is synchronized in G1/S phase by drug treatment (nocodazole) 
and infected, the cell population arrests in S phase for approximately 10 hours. If a cell 
culture is synchronized in G2/M phase by drug treatment (mimosine) and infected, the 
cells do not progress and remain arrested at G2/M. These results suggest that AcMNPV 
regulates two checkpoints: the Gl/S and G2/M phase cell cycle checkpoints (Braunagel 
et al. , 1998). 
It is thought that the G2/M phase arrest would benefit the virus late in infection, 
as ODV are being assembled. Our hypothesis is that the ODV envelope is formed from 
intranuclear microvesicles produced from the nuclear membrane. The nuclear 
membrane is most fluid during M-phase and a G2/M phase arrest may facilitate the 
induction of microvesicles. 
Cell Cycle Regulation 
Control of the eukaryotic cell cycle is accomplished primarily through the activity of 
cyclin dependent kinases (cdk's) which control the progression from one cell cycle 
phase to the next by the phosphorylation of various targets (Hutchison et al. , 1993). The 
activity of these kinases is regulated through association with their regulatory proteins, 
cyclins. In brief, the sequential activation or deactivation of cyclin/cdk complexes 
occurs through at least three different pathways: 1. Cell cycle phase specific expression 
and ubiquitin-mediated proteolysis of cyclins (Koepp et al. , 1999), 2. Phase specific 
activating phosphorylation or dephosphorylation events Qurse, 1990), 3. Phase specific 
recruitment of cyclins from the cytoplasm into the nucleus (Schafer, 1998). Each cell 
cycle phase has specific cyclin/cdk complexes which control progression through that 
phase: cyclin D/cdk(4 or 6) initiates proliferation from GO to Gl; cyclin E/cdk2 
promotes progression from Gl to S phase; cyclin A/cdk 2 is active in S and G2; lastly 
cyclin B/cdc2 promotes transition from G2 though M phase (Schafer, 1998). 
AcMNPV seems to manipulate the host cell cycle at checkpoints from GOB S 
phase and at G2/M phase. The mechanism of cell cycle control at these two checkpoints 
is well understood in mammalian cells and seems to be highly conserved among 
animals. Induction of growth in quiescent, or non-dividing, (GO-phase) cells involves 
the activity of cyclin D/cdk(4 or 6) dimers and the pRb/E2F complex (Weinberg, 1995), 
Extracellular signaling events, such as activation of a G-protein linked receptor tyrosine 
kinase by extracellular growth factors, are required for normal entry into the cell cycle 
from a non-dividing state. The final result of these extracellular signals is progression 
past the restricnon point, at which time normal cell cycle progression depends mostly 
upon internal signals and will progress through the entire cycle, ending in cytokinesis 
and re-entry into Gl. One downstream effect of mitogenic signal transduction pathways, 
such as the Ras+MAPK pathway, is the induction of transcription factors that activate 
the expression of cyclin D (Peeper, et al. 1997). Cyclin D is the regulatory partner of 
cdk's 4 and 6, whose functions seem to be redundant. Thus, cyclin D levels are induced 
during mid-Gl; once cyclin D binds cdk4/6, the dimer's cyclin kinase activity becomes 
activated and it can phosphorylate its substrate, pRb. pRb, the retinoblastoma protein, is 
a tumor-suppressor; its function is to bind and deactivate the transcription factor E2F. 
E2F-responsive genes are required for entry into S-phase. E2F's activation is 
accomplished in two steps: first, cyclin D/cdk(4 or 6) phosphorylates pRb's c-terminus, 
resulting in the release of HDAC (histone deacetylase, which helps to keep DNA in 
tightly-wound, transcriptionally inactive heterochromatin) and second, cyclin E/cdk2 
phosphorylates pRb's pocket domain to release and activate E2F (Harbour et al. , 1999). 
Although the mechanism is not completely understood, cyclin E/cdk2 activation first 
requires the activation of cyclin D/cdk(4 or 6); cyclin E activity peaks in late G I 
immediately prior to entry into S-phase. Adding another level of complexity to this 
regulatory process are CKI's (cyclin kinase inhibitors), which bind and inactivate cdk's 
(the p16 family: p15, p16, pig, and pl 9) or cyclin/cdk dimers (the p21 family: p21, p27, 
and p57) (Elledge, 1994). Of central importance to this model is p27, which can bind 
and inhibit both the cyclin D and cyclin E dimers, and p16, which triggers transcriptional 
repression by pRb/E2F (Zhsng et al. , 1999). 
Progression through G2/M phase is accomplished by the activity of cyclin 
B/cdc2 dimers (also known as the MPF, or mitosis promotion factor). Cyclin B/cdc2 
activation is controlled by the weel kinase/cdc25 phosphatase pair, which works in 
direct opposition to each other. Dephosphorylation by the cdc25 activates cyclin B/cdc2 
while phosphorylation by weel deactivates cyclin B/cdc2 +urse, 1990). DNA damage 
pathways prevent entry into M-phase (and the passage of mutated DNA to progeny cells) 
by inactivating cdc25 (Nurse, 1994). Cyclin B/cdc2 has multiple substrates, including 
histone Hl and nuclear lamina. It is thought that phosphorylation of lamins by the MPF, 
which leads to their depolymerization and the breakup of the nuclear lamina, increases 
nuclear membrane fluidity and facilitates the breakdown of the nuclear membrane into 
microvesicles (Dessev et al. , 1991). Degradation of cyclin B is required for the 
completion of mitosis. The APC (anaphase promoting complex), a ubiquitin ligase 
complex, recognizes a region present and highly conserved among cellular cyclins called 
the "destruction box" near the N-terminus of cyclin B. The APC then polyubiquitinates 
cyclin B on lysine residues adjacent to the destruction box, targeting it for proteolysis at 
the 26S proteasome (Glotzer et al. , 1991). The addition of non-degradable cyclin B (i. e. 
without a functional desnttction box) to mitotic cells causes an M-phase arrest. 
KC27i a Muitifunctionai Cyclln? 
Viruses use host replication machinery to synthesize and express their genomes. Some 
viruses directly hijack the host cell cycle regulatory machinery through the activity of 
virus-encoded proteins (Meijer et al. , 1997). For example, the Adenovirus EI A gene 
product can, among several functions, associate directly with pRb to activate the 
transcription factor E2F, which can cause quiescent rodent cells to proliferate from GO 
phase into active cell cycle progression (Grand et al. , 1994). Likewise, human 
cytomegalovirus induces cyclin E and cyclin B, among other regulatory proteins, to 
promote proliferation (Salvant et al. , 1998). Hepatitis B virus can stimulate cell cycle 
progression through the action of the viral HBX protein, which increases cdk2 and cdc2 
associated kinase activity and can bind and inactivate p53, a vital tumor-suppressor 
protein, to promote progression through both Gl/S and G2/M phases (Meijer et al. , 
1997). In addition to inducing cell cycle progression, viruses can arrest the cell cycle. 
Human immunodeficiency virus (HIV) causes a G2/M phase arrest through the activity 
the viral Vpr protein, which is thought to inactivate cyclin B/cdc2 complexes by 
activating the cellular phosphatase PP2A, an inhibitor of cdc25 and acnvator of weel 
(Poon et al. , 1998). 
Three virus-encoded cyclins were reported in the literature prior to EC27; 
these cyclins were found in herpesviruses: v-cyclin from herpesvirus saimiri (HVS), k- 
cyclin from human herpesvirus 8 (HHV8), and m-cyclin from murine 
gammaherpesvirus-68 (MHV-68) (Laman et al. , 2000; Virgin et al. , 1997). Both v- 
cyclin and k-cyclin form active complexes with cdk6, the catalytic partner of cyclin D, 
and are capable of phosphorylating pRb, the preferred in vitro substrate of cdk4/6; in 
addition, k-cyclin complexes are also capable of phosphorylating histone HI, the 
preferred in vitro substrate of cdc2 (Chang et al. , 1996; Jung et aL, 1994; Godden-Kent 
et al. , 1997). Both v- and k-cyclin/cdk6 complexes are resistant to inhibition by the 
CKI's p16, p21 and p27 (Swanton et al. , 1997). Ectopic expression of either viral cyclin 
prevents a CKI-induced Gl arrest in quiescent fibroblast cells. 3-D structure 
crystallography studies show that the insensitivity of v-cyclin/cdk6 complexes to p21 is 
due to structural differences between v-cyclin and cellular cyclins that lead to fewer 
protein-protein contacts between v-cyclin and p21; also, sequence differences in v-cyclin 
eliminate hydrogen-bonding interactions with p27 (Schulze-Gahmen et al. , 1999). 
Lastly, k-cyclin/cdk6 complexes can phosphorylate p27 its C-terminus, which activates 
p27 degradation (Mann et al. , 1999). These data suggest that herpesvirus cyclins 
contribute to the activation of cell cycle progression, and even neoplasmic 
transformation, of infected cells even when high levels of negative cell cycle regulators 
(e. g. CKI's) are present (Swanton et al. , 1999). 
As aforementioned, AcMNPV manipulates the host cell cycle at two 
checkpoints. We believe this abrogation of the host cell cycle is due to the activity of 
baculovirus-encoded proteins. Several experiments have led to the speculation that 
EC27 contributes to host cell cycle manipulation and furthermore that it may be a 
unique, multifunctional viral cyclin. 
Computer-assisted amino acid sequence homology analysis identified a region of 
sequence similarity between EC27 and the cyclin box, a gene region which is highly 
conserved among cellular cyclins. EC27 also has sequence homology with helixes 4 and 
5 of a larger conserved region called the cyclin fold, which forms contacts with cdk's 
(Noble et al. , 1997). EC27, however, lacks the characteristic destruction box of the 
cellular cyclins (Belyavskyi et al. , 1998). This data suggested that EC27 may have 
cyclin-like properties. EC27 immunoprecipitates were taken from infected SF9 cell 
lysates and then assayed for kinase activity. Like k-cyclin, EC27-associated complexes 
could phosphorylate both histone H I and pRb. Immunoprecipitates to individual 
cellular cdk's were taken from infected cells and then probed by western blotting for the 
presence of EC27. EC27 was shown to associate with cdk6, cdc2, and to a much lesser 
degree, with cdk7 (Belyavskyi et al. , 1998). The EC27 gene region is transcriptionally 
complex, and codes for three proteins with relative mobilities of 18 kilodaltons, 27 
kilodaltons, and 35 kilodaltons (the 35 kilodalton form corresponds is a fusion of the two 
smaller forms). Internal slippery sequences, or mRNA pseudoknot sites, that can cause 
ribosomal frameshifting may account for translational readthrough and the multiple 
forms of EC27 (Braunagel et al. , 1996). The 27 kD form of EC27 was detected in these 
immunoprecipitates. Preliminary studies also have shown that, like the herpesvirus 
baculovirus-encoded proteins. Several experiments have led to the speculation that 
EC27 contributes to host cell cycle manipulation and furthermore that it may be a 
unique, multi functional viral cyclin. 
Computer-assisted amino acid sequence homology analysis identified a region of 
sequence similarity between EC27 and the cyclin box, a gene region which is highly 
conserved among cellular cyclins. EC27 also has sequence homology with helixes 4 and 
5 of a larger conserved region called the cyclin fold, which forms contacts with cdk's 
(Noble et al. , 1997). EC27, however, lacks the characteristic destruction box of the 
cellular cyclins (Belyavskyi et al. , 1998). This data suggested that EC27 may have 
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could phosphorylate both histone H 1 and pRb. Immunoprecipitates to individual 
cellular cdk's were taken from infected cells and then probed by western blotting for the 
presence of EC27. EC27 was shown to associate with cdk6, cdc2, and to a much lesser 
degree, with cdk7 (Belyavskyi et al. , 1998). The EC27 gene region is transcriptionally 
complex, and codes for three proteins with relative mobilities of 18 kilodaltons, 27 
kilodaltons, and 35 kilodaltons (the 35 kilodalton form corresponds is a fusion of the two 
smaller forms). Internal slippery sequences, or mRNA pseudoknot sites, that can cause 
ribosomal frameshifting may account for translational readthrough and the multiple 
forms of EC27 (Braunagel et al. , 1996). The 27 kD form of EC27 was detected in these 
immunoprecipitates. Preliminary studies also have shown that, like the herpesvirus 
cyclins, EC27-associated kinase activity is insensitive to inhibinon by CKI's p21 and 
p15 (personal communication, Belyavskyi). 
AcMNPV abrogates the host cell cycle at Gl/S, which is controlled by cyclin 
D/cdk(4 or 6), and at G2/M, which is controlled by cyclin B/cdc2. Curiously, EC27 is 
present in complexes that contain the key regulatory elements of those two cell cycle 
checkpoints, which makes EC27 a strong suspect as a virus-encoded protein which may 
manipulate the host cell cycle. 
We speculate that EC27 has both cyclin B and cyclin D — like functions. Like 
cyclin D, EC27 is present in complexes with cdk6 and PCNA (proliferating nuclear cell 
antigen, a protein which has a role in the regulation of DNA replication) (Belyavskyi et 
al. , 1998). EC27 is a structural component of both the nucleocapsid and the idral 
envelope in ODV (Braunagel et al. , 1996). Thus, it is introduced into the cell 
immediately upon infection. The first checkpoint that the virus must exploit is entry into 
S-phase, as described earlier, when the virus must induce replication of its genome in the 
GO-phase midgut epithelial cell during primary infection. EC27 could promote an S- 
phase like environment through one of a few possible models: l. EC27 could simply 
mimic cyclin D and dimerize with cdk6, leading to the phosphorylation of pRb, 
Preliminary studies suggest that EC27/cdk complexes are insensitive to CKI inhibition; 
these complexes could induce entry into S-phase even in differentiated cells with high 
levels of inhibitors. 2. EC27 complexes could titrate CKI's such asp27 and p21 from 
the cell to activate cellular cyclin D or E complexes to promote the activation of E2F. ln 
addition to primary infection, EC27's possible cyclin D-like functions may help to 
explain "out of phase" viral DNA replication that can be detected as late as 60 hours post 
infection, long after the infected cells arrest at G2/M. This viral DNA replication cannot 
occur without the activation of S-phase specific genes; EC27's cyclin D-like functions 
could serve to activate these DNA replication genes "out of phase". 
Like cyclin B, EC27 is present in complexes with cdc2. This interaction may 
have an effect in the maintenance of the G2/M phase arrest observed at approximately 
18 hours post infection. Cellular cyclin B is degraded at approximately the same time as 
the initiation of the G2/M phase arrest. Levels of cdc2-associated histone Hl kinase 
activity are maintained long after cyclin B is no longer detectable (Braunagel et al. , 
1996). As aforementioned, degradation of cyclin B and its associated kinase activity are 
the major signal for exit from mitosis; without degradaflon of cyclin B, cells arrest in 
metaphase. EC27 may activate cdc2, forming a non-degradable (since it lacks the cyclin 
destruction box) cyclin-B homologue, which maintains the M-phase arrest as well as 
nuclear membrane fluidity, a factor which favors maturation of ODV envelopes. 
EC27 may be a unique protein. No other reported virus-encoded cyclin is 
multifunctional. No reported virus-encoded cyclin is a snuctural component of the 
virus, immediately introduced into the cell during infection to, perhaps, manipulate the 
host cell cycle. Studies into EC27 may therefore reveal novel mechanisms of cell cycle 
regulation. 
This report describes a study into three issues in the characterization of EC27. 
To ascertain if EC27 alone has cyclin-like activities, a yeast complementation assay was 
performed to determine if EC27 could rescue Gl cyclin deficient S. cerevtsiae. To 
determine the composition of the EC27-associated complex, iminunoprecipitations were 
taken and probed by western blotting for the presence of several putative-EC27 binding 
partners. Lastly, to resolve differences in the function of the 27 and 35 kilodalton forms 
of EC27, antisera which seem to be specific for each form were characterized in both 
immunoprecipitation and kinase assay experiments. 
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(A) Schematic of yeast 
complementation assay. 
EC27 was cloned into 
a yeast expression vector 
(pDB20) and trans formed 
into DL1, a CLN- strain 
conditionally viable on 
galactose-based media due to 
ectopic expression of CLN2. 
Cells can only grow on glucose- 
based media if the transformed 
gene can rescue the CLN- 
phenotype. 
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displayed, with the vector 
transformed listed atop each 
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RESULTS 
KC27 Does Not to Rescue Gl Cyclin (CLN) function in S. cerevisisfe 
To determine if EC27 alone has cyclin-like activities, a yeast complementation assay 
was performed, testing whether or not EC27 could rescue CLN-deficient yeast. Several 
cellular cyclins have been cloned by functional complementation in this assay (Leopold 
et al. , 1996; Day et al. , 1996). Saccharomyces cerevisiae strain DL1 (gift of Steven 
Reed, Scripps Research Institute) has its three native CLN loci (Gl cyclin) disrupted by 
insertional mutation and has a copy of CLN2 fused to the GAL I promoter integrated at 
the LEU2 chromosomal locus. The GALl promoter drives expression of CLN2 when 
cells are grown on galactose-containing media but represses CLN2 expression when 
cells are placed on glucose-containing media (Lew et al. , 1991). CLN function is 
required for yeast progression through Gl phase; CLN's dimerize with and activate 
cdc28, the single cdk in S. cerevisiae, which phosphorylates multiple targets to effect 
cell cycle progression (Forsburg et aL, 1991). There fore, DLI arrests upon glucose- 
based media and grows on galactose-based media. Full-length EC27 was generated by 
PCR from viral genomic DNA and cloned into the yeast expression vector pDB20 (gift 
of David McNabb, Massachusetts Institute of Technology), which is a high copy 
plasmid (2lt origin of replication) that drives expression froin the strong constitutive 
alcohol dehydrogenase promoter (PADH I) and contains a URA3 selectable marker 
(Becker et al. , 1991). DLI was transformed by a high efficiency lithium acetate method 
with pDB20 + EC27 (Gietz et al. , 1992). Transformants were plated on both solid media 
lacking uracil (to select for the plasmid) and containing glucose (to select for rescue of 
CLN loss) and media lacking uracil and containing galactose (to monitor growth with 
ectopic expression of CLN2), Growth was observed on galactose-containing plates (top 
row, Figure 1) but not on glucose-containing plates (bottom row, Figure 1). Confidence 
in the success of the transformation can be estimated by the negative control (there was 
no growth observed on transformation plates for yeast transforined without a URA3+ 
plasmid, data not shown), in that the rate of reversion for URA3 is low (&I /o), which 
ensures that the growth on galactose plates is specific for the presence of the URA3 gene 
on pDB20 or pDB20+EC27. 
These data suggest that EC27 cannot rescue CLN loss in yeast. It should be 
noted that not all cellular cyclins complement CLN loss in DL I on glucose. For 
example, Drosophila G2 cyclins fail to rescue DLI (Leopold, et al. , 1991). This assay 
examines only if a gene can replace the function of CLN2, thus presumably testing if the 
gene product of interest can dimerize with and activate cdc28. Thus, not all cellular 
cyclins would be expected to test positive in this assay since different cyclins from 
higher eukaryotes interact with a wide variety of divergent cdk's, some of which have 
only a low level of sequence similarity with cdc28 (the yeast homologue of cdc2). 
Characterization of the EC27-associated Complex 
Prior to the inination of studies to determine the composition of the EC27-associated 
complexes, several background studies were done to optimize the conditions for 
immunoprecipitation. Two working antisera (rabbit polyclonal antibodies) to EC27 
were used; both antisera were raised against purified, recombinant EC27. The first 
studies into EC27 produced and used the first antisera, ¹7351, which was raised against 
a GST-EC27 fusion (from here, referred to as EC27-GST or 7351) (Braunagel et al. , 
1996 and 1998; Belyavskyi et al. , 1998). More recent studies by have produced a 
second antisera (¹11209, referred to as EC27-IIIS or 11209), which was raised against 
affinity purified HIS-tagged EC27 (unpublished data, Braunagel et al. , 1999). The 
studies described here characterize the performance of these antibodies, especially in 
comparison to each other, in terms of western blotting, kinase assays, and 
immunoprecipitations. 
In the analyses of these results, the buffer conditions used here must be taken into 
consideration. For the majority of the experiments described, immunoprecipitates were 
taken in RIPA lysis buffer, a relatively stringent buffer containing 0. 1'/o SDS. Weakly- 
associated protein complexes may dissociate in this buffer. In latter experiments, 
immunoprecipitates were taken in a less stringent HEPES-based buffer containing only 
non-ionic detergents. Thus, experiments using RIPA buffer (figures 2, 3, 4A, and 5) 
may be too stringent to detect signals resulting from weak protein-protein interactions. 
Protein complexes immunoprecipitated with both the EC27-GST and EC27-HIS 
antisera were taken from whole cell lysates of SF9 cells harvested at 48 hours post 
infection by AcMNPV strain E2. To optimize the signal to noise ratio and to verify a 
linear signal response between the amount of antibody used in precipitation and the 
amount of EC27 detected by western blotting, immunoprecipitates were taken using 5, 
10, and 15 ul of either antiserum. These immunoprecipitates were resolved by SDS- 
PAGE and probed by western blotting with the same antisera. An immunoreactive 
protein with a relative electrophoretic mobility of 27 kilodaltons was detected by the 
EC27-GST antiserum in complexes precipitated with the same antiserum. On this form 
of EC27 (i. e. using the EC27-GST antisera) all previous studies have been performed. 
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Figure 2. Detection of EC27 In EC27 Immunopreclpltates using Antisera 7351 and 11209 
Immunoprecipitates were taken from 48-hr. post infection cell lysstes using EC27 ant(sera 7351 
and 11209. The amount of antiserum used to precipitate complexes is indicated. Precipitated 
protein complexes were separated by SDS-PAGE snd EC27 wus detected by western blot using 
both sntisera. (A) Western blot of 7351 and 11209-immunoprecipitates and infected cell Iysate 
probed with antiserum 7351. In 7351-immunoprecipitates and infected cell Iysate, s 27 kilodalton 
protein is detected (lanes 1-4). (B) Western blot of 7351 and 11209-immunoprecipitates 
and infected cell lysate probed with antiserum 11209. In 11209-immunoprecipitates 
and infected cell lysate, a 35 kilodalton protein is detected (lanes 1, 5-7). 
Also, an immunoreactive protein with a relative electrophoretic mobility of 35 
kilodaltons was detected by the EC27-HIS antiserum in complexes precipitated with the 
same antiserum. EC27-HIS and EC27-GST antisera do not cross-react with the same 
target protein band. The 35 kilodalton EC27 form was not detected by the EC27-GST 
antiserum; the 27 kilodalton EC27 form was not detected by EC27-HIS antiserum. 
Since these antisera were raised against the same protein (even though in different form: 
GST fusion versus HIS-tag) and are polyclonal antibodies, they should recognize the 
same protein. They, however, recognize proteins of two different molecular weights. 
Assuming that there were no problems with recombinant EC27 proteins used to raise the 
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Figure 3, EC27-associated Kinase Activity 
(A) To ensure that EC27-associated kinase activity is specific to EC27 and to ensure the maximum 
activity was being assayed, a pH dependence of EC27-associated kinase activity was determined. 
Immunoprecipitates were taken using EC27-7351 antiserum trom both infected and uninfected 
SF9 cells, and the kinase activity of the precipitated protein complexes was determined using 
histone H 1 as the in vitro substrate in assay buifers of pH 6. 8 to 7. 4. The phosphorylated histone 
H 1 bands are shown. (B) The histone band is quantitated by Spot Denso function of the 
Chemimager soihvare package. (C) To compare the kinase activity of complexes precipitated with 
the EC27-7351 and EC27-11209 antisera, immunoprecipitates were taken with those antibodies 
and assayed for kinase activity using histone Hl as the in vitro substrate. To verify a linear signal 
response, a range of 5 to 15 ul of antiserum was used in the immunoprecipitation. 
Antisera volumes are indicated. (D) The phosphorylated histone Hl band 
is quantitated by Spot Denso function of the Chemimager software package. 
antisera, it appears that the EC27-GST antiserum is specific for the 27 kilodalton form of 
EC27 and EC27-HIS antisera is specific for the 35 kilodalton form of EC27. 
Since most of our interest in EC27 is a result of its presence in precipitated 
protein complexes with cyclin kinase activity (presence of cdc2 and cdk6, ability to 
phosphorylate in vitro cyclin kinase substrates histone Hl and pRb), we directed our 
efforts into the optimization of the conditions for the immunoprecipitation and kinase 
assay procedures. 
The kinase assay procedure which had been used previously was optimized for 
use in mammalian cell system, at a pH of 7. 5 to mimic the mammalian intracellular pH. 
The insect intracellular pH is soinewhat lower, closer to 7, 0. To ensure that our 
experimental conditions maximized the signal response, we performed kinase assays in 
reaction buffers from a range of 6. 8 to 7 4. 
To establish a "zero-point" activity, or kinase activity in the EC27-associated 
complexes not specific to EC27, immunoprecipitates were taken from uninfected SF9 
cells in addition to infected SF9 cells. The maximum activity in precipitates from 
infected cells, denoted 100% activity with arbitrary units, is observed at a reaction buffer 
pH of 7. 0 (figure 3A lane 3, figure 3B solid line). Percent activities drop off 
precipitously in bell curve type dependence at both lower and higher pH's. Thus, the 
optimal conditions of these kinase assays in insect cells are, as might be expected, closer 
to the intracellular environment of insect cells at pH 7. 0. The maximum activity in 
precipitates from uninfected cells is 52. 5% (based on IDV, or integrated density values 
from Chemimager software analysis), which is observed at pH 7. 0 (figure 3A lane 8, 3B 
dashed line). Whether this level of activity is constituted by cellular protein complexes 
with kinase activity that are precipitated by the EC27-GST antibody (perhaps due to 
structural homology between EC27 and cellular cyclins) or that this 52. 5'/o activity is the 
baseline level of activity of this in vitro assay (due to autophosphorylation ofhistone Hl, 
etc. ) cannot be determined here. 
The kinase activity of protein complexes precipitated with both the EC27-GST 
and EC27-HIS antisera was assayed. In addition to a directly comparing the protein 
complexes precipitated by these two antisera, these experiments were performed to 
optimize the signal to noise rano and to establish the limits of a linear signal response 
between the amount of antibody used to precipitate complexes and the detectable kinase 
activity. A linear increase in kinase activity signal and amount of antiserum used in 
precipitation is observed with the EC27-GST antiserum but not with the EC27-HIS 
antiserum (figure 3C, D). 100'lo activity, based in arbitrary units, is derived from the 
activity of the EC27-GST 15 ul precipitate (fligure 3C lane 3, 3D column 3). The 
average signal from EC27-HIS precipitates is 44. 4'to + 6. 65o (figure 3C lane 4-6, 3D 
columns 4-6). Although it must be kept in mind that the kinase acflvities measured here 
reflect stringent buffer conditions, the lack of positive signal response to antiserum 
concentration and the fact that "baseline" activity of a EC27-GST immunoprecipitate is 
approximately 50/o while the average EC27-HIS activity is 44'/o may indicate that the 
EC27-HIS immunoprecipitate's activity is not significant when compared to background. 
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Composition of the KC27-associated complex 
Perhaps the most informative data to be determined about EC27 is the identity other 
proteins with which it interacts in the cell. Our evidence may suggest the EC27, unlike 
other viral cyclins, operates in a complex larger than the traditional 1 cyclin: 1 cdk 
active heterodimer; therefore the strongest indications of EC27's function will be in the 
protein coinposition of its complexes. 
In preliminary studies, eight clones in a yeast-2-hybrid screen identified another 
viral nucleocapsid protein, ORF101, as an EC27-interacting protein (unpublished data, 
Braunagel and Marcano, 1998). To confirm this data biochemically, protein coinplexes 
were precipitated using ORF101, EC27-GST, and EC27-HIS antisera from uninfected 
and infected SF9 cells (60 hr post infection), separated by SDS-PAGE, and probed by 
western blot with the same set of antisera. First, we probed EC27 (both antisera) 
immunoprecipitates with ORF101 antibody. ORF101, a protein with a relative 
electrophoretic inobility of approximately 41 kilodaltons, was detected in the EC27-HIS 
immunoprecipitate from infected cells as well as the infected cell lysate (figure 4A lanes 
6, 2) but not in the EC27-GST immunoprecipitates (figure 4A lane 4). Using the EC27- 
HIS antisera to probe the immunoprecipitates, EC27 (35 kilodalton form) was detected 
in the ORF101 immunoprecipitate from infected cells as well as the EC27-HIS 
immunoprecipitate from infected cells and the infected cell lysate (figure 4B lane 3, 5, 1), 
but not in the EC27-GST immunoprecipitates (figure 4B lane 7). Using the EC27-GST 
antisera to probe the immunoprecipitates, EC27 (27 kD) was only detected in the 
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Figure 4. ORF101 is a Component of the EC27-associated Complex 
Complexes were precipitated fmm uninfected and 60 hr post infection SF9 cells using 
antisera to ORF101, EC27-7351, EC27-11209. Immunoprecipitates were separated 
by SDS-PAGE and probed by western blotting. (A) Western blot using 
ORF101 antiserum to probe EC27-7351 and 11209 immunoprecipitates. 
A 41 kilodalton protein is detected in the infected cell lysate (lane 2) and the 
11209-IP from infected cells (lane 5). (B) Western blot using EC27-7351 and 
11209 antisera to probe ORF101, EC27-7351, and 11209 immunoprecipitates. 
For the 11209 probe, a 35 kilodalton protein is detected in infected cell lysate (lane I), 
ORF101 IP from infected ceHs (lane 3), and 11209 IP from infected cells (lane 5). 
For the 7351 probe, a 27 kilodalton protein is detected in the infected cell lysate 
(lane 9) and the 7351 IP from infected cells (lane 15). 
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positive controls, the infected cell lysate and the EC27-GST immunoprecipitate from 
infected cells (figure 4B lanes 9, 16). Thus, ORF101 co-precipitates with the 35 
kilodalton form of EC27 and EC27 (same form) co-precipitates with ORF101. This data 
is strong evidence that ORF101 does associate with the 35 kilodalton and does not 
associate with the 27 kilodalton form of EC27, especially since the experiments shown 
in figure 5B were performed in the less stringent HEPES buffer system. 
A wide range of other putative EC27-binding partners were analyzed by a similar 
method: precipitation of protein complexes using EC27 antisera followed by western 
blot analysis probing with antibodies for the putative EC27 binding partner. Analysis of 
all major cellular eukaryotic cyclins was performed (cyclins A, B, D, and E) in this 
manner. These analyses highlighted some major limitations of the technique. EC27 
immunoprecipitates were probed for cyclin B using a mouse monoclonal antibody (Santa 
Cruz Technologies, antibody type GNS1). Cyclin B was detected in both 48 hour 
infected and uninfected cell lysates, Hela (mammalian cell line) cell lysates, and a 
commercially available western blotting positive control (figure 5A, lanes 1, 2, 7, 8). No 
cyclin B was detected in the EC27-GST and EC27-HIS immunoprecipitates (figure 5A, 
lanes 3-6). Two caveats must be taken into consideration: first, this data is not consistent 
with previous data, which demonstrated that cyclin B was degraded in infected cells 
much earlier in the infection process. These studies used a different annbody (Santa 
Cruz, cyclin B rabbit polyclonal antibody H-432). It unfortunately appears that these 
data are antibody-dependent for, at least, commercially available antibodies that are 
almost exclusively raised in mammalian systems. Second, since these experiments were 
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also performed in the more sningent RIPA buffer system, a weak cyclin B association 
may not be detected here. With these caveats, it appears that, under the experimental 
conditions used with these studies, cyclin B does not associate with the EC27-associated 
complex. 
Attempts to analyze EC27 immunoprecipitates for the presence of other cellular 
cyclins with commercially available antibodies failed. In figure SB, a western blot of 
EC27 immunoprecipitates using Cyclin Al antibodies (Santa Cruz Technologies, cyclin 
Al rabbit polyclonal antibody M-20) is shown. This blot typifies other studies using 
commercially available polyclonal antibodies. No cyclin A can be detected at the 
exposure used (approximately 10 seconds) in the infected and uninfected cell lysates 
(figure SB lanes 1, 2). Overexposure conceals any distinct bands in lanes I and 2 with 
background signal and oversaturates the lanes that contain immunoprecipitates (figure 
5B lanes 3-6). Thus, the signal generated from background and immunoprecipitate- 
specific bands is much greater than the signal from the true epitope. This undesirable 
signal is due to two problems: first, rabbit antibodies are used during both the western 
blotting and immunoprecipitation steps and thus the rabbit IgG, heavy and light chain, 
generate signal. Second, under the conditions used, these mammalian antibodies seem 
to have a low affinity for their insect target proteins. Nonetheless, a band of 
approximately 60 kilodaltons is detected in HeLa cell lysate, which is the correct 
electrophoretic mobility of mammalian cyclin Al (figure 5B lane 7). However, any 
band of this mobility would be concealed by the heavy chain IgG band in the lanes 
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Figure 5. Immunoprecipitation & Western Blottlag Technique Results Analysis 
Immunoprecipitations and western blotting done as previous (see figure 2, 4). 
A) EC27 immuaoprecipitates probed with Cyclin B mouse monoclonal antibodies. A 
62 kilodalton protein is detected in the uninfected S19, infected SF9, and hela cell lysates 
(lanes 1, 2, 7), B) EC27 immunoprecipitates probed with Cyclin A rabbit polyclonal 
andbodies. A 60 kilodalton protein is detected in hela cell lysate (lane 7). C) Determination 
of Signal/Noise ratio for a band of the lane 7-cyclin A band intensity buried in 
immunoprecipitation-specific signal. Total signal intensity per lane is quantified by the Spot 
Denso function of the Chemimager software package ("IDV", or integrated density value, 
column). These intensities are normalized for background signal 
(total IDV - mean background IDV; "normalized IDV" columa). The signal/noise ratio 
for the normalized signals of a putative cyclin A band (olane 7", column 2) buried in 
immunoprecipitation-specific bands ("mean lanes 3-6", column 2) 
thea is determined (151152 IDV units/[1130256 IDV units — 151152 IDV units]; 
"Signal/Noise %" column). 
containing immunoprecipitate (figure 5B lanes 3-6). In general practice, any band with a 
mobility of 45-55 kilodaltons would be extremely difficult to resolve from heavy chain 
IgG in the gel technologies used here. Lastly, we calculated the signaVnoise ratio for the 
cyclin A band in th'e Hela lysate lane (figure 5B lane 7) if it had been present in an 
iinmunoprecipitate-containing lane (figure 5B lanes 3-6). This calculation assumes a 
cyclin A band is present but not manifest inside an "average" immunoprecipitate signal. 
The ratio is approximately 15 lo (figure 5C). This low signal/noise ratio would make any 
type of analysis on this data tenuous. 
DISCUSSION 
EC27 May Not Function Independently as a Cyclin 
The failure of EC27 to rescue CLN deficient cells suggests that EC27 alone may not be a 
functional cyclin. "Alone. . . functional cyclin" here means strictly that EC27 cannot 
replace the function of a yeast Gl cyclin, which presumably means that EC27 cannot 
dimerize with and activate cdc28, the yeast cdk responsible for progression through all 
cell cycle phases. Some cyclins from higher eukaryotes, for example Drosophila G2 
phase cyclins, fail to rescue CLN deficient yeast (Leopold, et al. , 1991). Since cyclins 
are a diverse family of proteins that interact with diverse family of cdk's, the failure of 
any given cyclin to bind any given cdk may not be significant at face value in 
determinanon of the functionality of a cyclin protein. In other words, a positive result in 
the yeast complementation assay would strongly indicate EC27 is a functional cyclin; 
however, one cannot conclude from a negative result that EC27 is not a functional 
cyclin. Anegativeresultcouldbeduetotwopossibleconditions: l. EC27candimerize 
with and activate cdk's, but not cdc28. 2. EC27 is not able to dimerize with and activate 
cdk's at all. However, we cannot dismiss this result altogether as the former condition. 
Of the major animal homologues analyzed, EC27 is most homologous to cyclin B (with 
an overall sequence similarity of 18%), and EC27 is known to associate with cdc2, the 
animal homologue of cdc28 (Belyavskyi et al. , 1998). Those who developed this 
technique noted that the majority of clones isolated by functional complementation in 
DL1 to rescue the CLN- phenotype were cyclin B clones (Lew, et al. , 1991). We can 
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speculate, then, that EC27, a close homologue to a cyclin which complements very 
strongly in this assay, has a fair probability of successful complementation (in that, 
through the homology argument, it has a fair possibility of being able to dimerize with 
cdc28, a homologue of cdc2). Since EC27 fails to complement, this experiment lends 
credence to the latter condition, that EC27 may not be able to activate any cdk. If that 
result holds true, we can speculate that EC27 may only be functional as part of a larger 
complex. We have not yet established whether or not other cellular cyclins are present 
in the EC27-associated complex and are themselves responsible for the EC27-associated 
kinase activity. The suggestion from the complementation assay, that EC27 may not be 
a traditionally functional cyclin, supports in principle a model in which EC27 serves in 
these protein complexes that have kinase activity not to activate cdk's but to regulate the 
activities of the pre-existing cyclins. 
The EC27-GST and EC27-HIS associated Complexes are Distinct 
Although it seems highly unlikely, it appears that the EC27-GST and EC27-HIS 
antiserum cross-react specifically with different molecular weight forms (EC27-GST:27 
kD, EC27-HIS:35 kD) of EC27. We, therefore, have at our disposal a very powerful 
molecular tool: the ability to resolve different forms of same protein without having to 
resolve on the basis of mass or electrophoretic mobility. 
Of significant import is the observation that as much as half of the maximum 
kinase activity signal from the EC27-GST immunoprecipitate can be precipitated from 
uninfected cells. Whether this background signal is due to a baseline rate of 
28 
phosphorylation in the assay (autophosphorylation, nonspecific catalysis, etc. ) or due to 
other proteins (cellular kinases, cyclins, or activating factors) which the EC27-GST 
antisera precipitates cannot be resolved here. However, the same observation was made 
previously, as EC27-GST immunoprecipitates taken from cells very early in infection, 
before EC27 protein is detectable inside the cell, have kinase activity against pRb 
(Belyavskyi et al. , 1998). 
These kinase assay experiments were done in the more stringent RIPA buffer 
system, and thus presumably the kinase activities are reduced significantly as compared 
to activities measured using a less stringent system. We can assert definitively that the 
EC27-HIS immunoprecipitate from infected cells (44'to) has less acnvity than the EC27- 
GST immunoprecipitate from infected cells (100'/o). We can assert that EC27-HIS 
immunoprecipitates from infected cells have less activity (44'/o) than the EC27-GST 
immunoprecipitate from uninfected cells (52. 5'lo). It may be the case that EC27-HIS 
immunoprecipitates do not have a significant level of kinase background compared to 
the "zero-point", or baseline activity. The problem is that we cannot necessarily 
establish the baseline level of activity for the EC27-HIS associated complex with the 
baseline for the EC27-GST associated complex (we define the baseline to be the activity 
precipitated from uninfected cells). There are two possible conditions: if the EC27-GST 
baseline is significantly different than the undetermined EC27-HIS baseline (for 
whatever reason: EC27-GST precipitates cellular factors that enhance the kinase activity, 
EC27-HIS simply precipitates less total protein, etc. ) then we cannot compare the EC27- 
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Figure 6: Comparison of 11209- and 7351-associated Kinase Activity 
Baseline drawn assuming the 7351 and 11209 baselines do not significantly 
differ. 
HIS associated activity to the EC27-GST baseline. If the EC27-GST baseline is not 
significantly different from that of the EC27-HIS baseline (i. e. , the baseline is due to 
nonspecific factors) we can compare EC27-HIS associated activity to the EC27-GST 
baseline. We would then speculate the EC27-HIS associated kinase activity may be 
insignificant under the experimental conditions used. In plain terms, the EC27-HIS 
associated activity is less than the EC27-GST associated activity and it may or may not 
be of significant magnitude under these buffer conditions. Further experimentation is 
warranted. 
What does this result suggest about the function of the two forms of EC27? If 
future experimentation (under less stringent conditions with a proper measure of the 
EC27-HIS baseline) demonstrates that the EC27-HIS-associated kinase activity is indeed 
insignificant, then any models of EC27 must reflect this: the 35 kD EC27-associated 
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Figure 7: Components of KC27-associated Complexes 
complex certainly would not function to activate cdk's; its complex would not even be 
capable of cyclin kinase activity. Thus, the 27 and 35 kD forms of EC27, which may be 
isolated spatially and temporally, would also be functionally distinct. 
ORF101 is a Member of the (35 kilodalton) EC27-associated Complex 
Reciprocal immunoprecipitation experiments demonstrated that ORF101 interacts with 
35 kD-EC27. ORF101 is also a structural protein of AcMNPV, meaning that it is 
introduced into the cell immediately upon infection. Interestingly, like EC27, it has 
multiple forms in the cell (as recognized by western blot, one form with a relative 
mobility of 41 kilodaltons and the other at 28 kilodaltons). ORF101 contains an LXCXE 
motif; this motif is a pocket-protein or pRb binding consensus motif. ORF101 has 
sequence similarity to cellular cyclins in the region of the cyclin fold that interacts with 
p27 (unpublished data, Braunagel et al. , 1999). 
ORF101 does not associate with 27-kD EC27 under any buffer conditions. This 
result also supports the hypothesis that the 35-kD EC27 and 27-kD EC27 associated 
complexes may be distinct in both function and composition. The 27-kD EC27 complex 
inay represent a pool of EC27 involved in the regulation of cyclin kinase activity. The 
35-kD EC27 complex may represent a pool of EC27 involved in regulating pRb 
(especially since EC27 itself has an LXCXE-related motif) that may not contain cyclin 
kinase activity. We have no reason to assume that the binding partners between the two 
forms of EC27 are identical. Furthermore, we have no reason to assume that the 
composition of either complex remains static spatially or temporally. 
Limitations in the Western Blotting of ImmunoprecipitNes 
As shown in figure 5A and more dramatically in figure 5B, the percentage of true signal 
in a western blot of immunoprecipitates using polyclonal antibodies from the same 
species in both procedures is quite low. As estimated by the signaVnoise ratio 
calculation in figure 5C, the signal specific to the target protein may be as low as 155'. 
A lower ratio is probably more correct, as the Spot Denso function of Chemimager 
seems, at least by the naked eye, to be biased towards reading low optical densities as 
higher than actual. This signal/noise issue is a problem on three accounts: 
1. Mammalian antibodies have poor affinity to insect proteins, which exacerbates the 
amount of noise and often yields unreliable bands for the purported protein target. 2. 
Signal bands are buried in background bands: the signal of interest may be buried in the 
very significant lgG bands (again a problem when using same-species antibodies) or 
other "background" bands, e. g. bands from a cross-reactive protein which is not protein 
of interest. 3, Multiple banding (not banding due to IgG) yields several bands of 
approximately the "correct", or reported, mobility of the target protein. These forces 
generate the temptation to simply test multiple commercially-available antibodies for a 
target protein and choose the antibody which yields a one band of many bands on the 
blot with a relative mobility that is closest to the reported mobility. No data based on 
such an antibody can be deemed reliable. Furthermore, these assays direct energy away 
from techniques which may be more successful, since they avoid the aforementioned 
problems, such as ¹erminal sequencing and column pull-downs. On a more 
fundamental level, we have no idea what proteins are present in the EC27 associated 
complexes, especially as it becomes clearer that we are probably dealing with multiple 
complexes, and therefore to probe these complexes for suspected proteins is inefficient. 
Rather, high-throughput screens or techniques, which do not first require a guess at what 
is present, should be used. Lastly, we currently are faced by inconsistent data (based in 
results from different antibodies to the same protein) on cyclin B, Figure SA suggests 
that it is not a member of the EC27-associated complexes in the buffer system used. 
Previous data suggests that cyclin B is not present in cells late in infection but Figure 5A 
detects cyclin B at 48 hours post infection. 
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Models of EC27 Function 
Before we discuss models of EC27 function, a discussion of those models of EC27 
function that these data fail to support is warranted. If the negative result of the yeast 
complementation assay is true, then no model in which EC27 dimerizes with and 
activates a cdk is valid. Thus, EC27 may not be able to bind cdk6 to mimic cyclin D and 
phosphorylate pRb directly to activate E2F and induce S-phase, Likewise, EC27 may 
not be able to bind cdc2 to form a non-degradable cyclin B homologue, phosphorylate 
nuclear lamins, and create the G2/M phase arrest. However, if we postulate that EC27 
performs these tasks, but instead of activating cdk's themselves bind to cellular 
cyclin/cdk complexes and regulate their activity, then the above models would be 
possible with the respective modifications. If the result that 35-kD EC27 complexes 
have no significant kinase activity is confirmed, then the above models are further 
limited to include only the 27-kD form of EC27. The model of EC27 titrating inhibitors 
is neither confirmed nor denied by these results; that model requires neither kinase 
activity nor direct activation of cdk by EC27. 
The ORF101/35 kD-EC27 binding may have significant functional implications. 
Several oncogenes from DNA tumor viruses contain LXCXE motifs. These oncogenes 
function by displacing pRb from E2F, thus uncoupling E2F activation from pRb 
phosphorylation. E2F can then induce entry into S-phase without activation of cyclin D 
or cyclin E complexes and their phosphorylation of pRb. These oncogenes can induce 
proliferation in quiescent cells by this mechanism (Funk et al, , 1998). The 
EC27/ORF101 model would function identically: EC27/ORF101 (both contain LXCXE 
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Figure 8. Mechanism for S-phase induction by ORF101/EC27 
or related motifs) bind and displace pRb, activating entry into S-phase. This model 
could account for how ORF101/EC27, both structural proteins introduced into the cell at 
infection, could induce S-phase entry during primary infection, or how they could induce 
viral DNA replication (again induction of an S-phase like environment) late in infection. 
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EXPERIMENTAL PROCEDURES 
Yeast Strains and Media 
DL1 is derived from strain BF264-15Dau, MATct ade1 his2 leu2-3 112trp1-la ura3 
(Lew, et al, 1991), DL1 was disrupted for cln1 (cln1:: TRP1), cln2, and cln2 (unmarked 
disruption with insertion at XHOI site of cln2). DL1 contains a GAL1::CLN2 fusion 
integrated at the LEU2 chromosomal locus. DL1 was grown on YEPG (2'ro galactose, 
1 /o yeast extract, 2/o bacto-peptone). 
Yeast Transformation 
Yeast transformations were done by high-efficiency lithium acetate method (Gietz et al, 
1992). 5 mls YPEG was inoculated with a single DL1 colony from YPEG plate and 
grown overnight at 30'C. 50 mls of YEPG was inoculated with the sufficient overnight 
culture to give A660 = 0. 2 (2 x 10E6 cells/ml). Cells were grown to A660 = 1. 0 (2 x 
10E7 cells/ml). Cells were pelleted by centrifugation (1000xg), washed in 10 mls sterile 
water, re-pelleted by centrifugation, and suspended in 1 ml sterile water. Cells were then 
transferred to 1. 5 ml sterile microfuge tube, tap-spun, and resuspended in 1 ml sterile TE 
/ LiOAc (0. 01M Tris-HC1, 0. 001M EDTA, pH 7. 5, 0. 1M LiOAc pH 7. 5, adjusted with 
diluted acetic acid). Cells were then were pelleted by centrifugation (1000xg) and 
resuspended in 0. 25 mls TE / LiOAc (4 x 10E9 cells/ml). 50 ul yeast cells were mixed 
with transforming DNA (. 5 ug) and 5 ul single stranded carrier DNA (10 mg/ml, boiled 
and quick chilled on ice) in a 1. 5 ml microfuge tube. 300 ul sterile PEG solution (40'10 
PEG 4000, 1X TE / LIOAc) was added and then the mixed thoroughly. Cells were 
incubated at 30'C for 30 minutes and heat shocked at 42'C for 15 minutes. Cells were 
then pelleted and plated on minimal selective media (Sc-ura galactose or Sc-ura 
glucose). Approximately 500 transformants/plate were observed. 
Recombinant DNA Manipulation 
Yeast expression vector pDB20 contains the ADH1 promoter and 2lt origin for high 
copy, high level complementation analysis (Becker et al. , 1991). pDB20 was prepared 
by maxi-prep (large scale alkaline lysis) from E. coli strain DH5a. pDB20 was prepared 
for EC27 insertion by Hindlll digestion followed by calf intestinal phosphatase (CIP) 
treatment and electroelution. EC27 was generated by PCR from the eco-B fragment of 
AcMNPV genomic DNA using primers which generated full length EC27 (-900 bp) 
with 5' and 3' Hindlll sites. EC27 was prepared for ligation with pDB20 by digestion 
with Hindlll (24 hours) and electroelution. Ligation reactions were incubated overnight, 
float dialyzed, and electroporated into DH5n. Clones were miniprepped and subjected 
to Hindlll and Notl/Pstl diagnostic restriction analysis. pDB20+EC27 in the correct 
orientation was then prepared for yeast transformation by maxi-prep. 
Insect Cell Lines and Virus 
Spodoptera frugiperda IPLB-Sf21-AE clonal isolate 9 (SF9) cells were cultured in 
suspension at 27 C in TNMFH medium and supplemented with 10'io fetal bovine serum. 
Cells are maintained in suspension culture at I-2X10 cells/ml prior to infection. 
AcMNPV strain E2 was for infection at a m. o. i. of 20. 
Immunopreclpltatlon 
Protein complexes precipitated with EC27 antisera were subjected to in vitro kinase 
assay or western blot analysis. SF9 cells were harvested into RIPA lysis buffer (more 
stringent, 0. 1'/0 SDS, 50 mM Tris pH 7. 5, 150 mM NaCI, 0. 5'/o Triton X-100, 0. 5'ro 
deoxycholate) or HEPES lysis buffer (less stringent, 50 mM HEPES pH 7. 5, 150 mM 
NaCI, 0. 5'to Triton X-100), the protein concentration determined, aliquoted to 200 total 
protein ug/tube, and stored at -80'C. 200 ug total protein of whole cell lysate was 
dissolved in I ml RIPA or HEPES lysis buffer with 0. 01X protease inhibitors cocktail 
(Sigma). Cells were incubated on ice 30 minutes, passed through a 27 gauge needle 
twice, and microcentrifuged for 10 minutes at 2. 5Krpm. The supernate was transferred 
into new microfuge tube and pre-cleared by adding 0. 20 ug normal animal IgG (Santa 
Cruz Biotechnolgies), incubating while rotating at 4'C for I hr. 25 ul 50'io protein A 
beads slurry (pre-equilibrated in lysis buffer, Sigma) was added and then incubated 
while rotating at 4'C for I hr. The beads were pelleted by microcentrifugation for 3 
minutes, 2. 5Krpm. The supernate was put into new tubes and immunoprecipitates were 
taken by adding 1-2 ug purified IgG (Santa Cruz antibodies) or 5-15 ul serum (EC27- 
7351 and 11209, ORF I 0 I) and incubated while rotating at 4' for 1 hr. 25 ul 50'lo protein 
A beads slurry (pre-equilibrated in lysis buffer) was added and then incubated while 
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rotating at 4'C for I hr. Precipitates were collected by microcentrifugation at 3 minutes, 
2. 5Krpm and washed 2 times in Beads Washing Buffer with 0. 01X Protease Inhibitor 
Cocktail (50 mM Tris pH 7. 5, 240 mM NaC1, 0. 1'/0 NP-40, 5 mM EDTA). 
in vitro Kinase Assay 
Kinase assays perforined as described by Belyavskyi et aL, 1998. Following 
immunoprecipitation, the precipitates were washed 2 times in kinase reaction buffer (50 
mM Tris pH 7. 0, 10 mM MgC12, I mM DTT). Kinase reactions were initiated by 
resuspending the immunoprecipitates in a 20 Itl reaction mixture containing I p. g of 
Histone Hl, 100 Itm ATP, and 50 pCi of P-ATP. Reactions proceeded for 30 minutes 
and then were terminated with SDS sample loading buffer. Samples were then boiled 3 
minutes and loaded on a 15'10 SDS-PAGE gel. Phosphorylated bands of substrate were 
quantified by Spot Denso function of the Chemimager Software package. 
Western Blot Analysis 
Protein samples (immunoprecipitates or cell lysates) were prepared as described above. 
SDS sample loading buffer (1 5/0 SDS, 0 5 mercaptoethanol, 25 mM Tris pH 6 8, 7/0 
glycerol) was added, proteins were separated using a 12'to separating gel SDS-PAGE 
using the method described by Laemmli et al. , 1970 and transferred to Immobilon-P 
PVDF membranes (Millipore). Membranes were blocked in TTBS-Blotto (5'10 nonfat 
dry milk, 150 mM NaCI, 10 mM Tris pH 7. 5, 0. 1'/0 Tween-20) for I hr to overnight. 
Primary antibody was added to TTBS-Blotto at a concentration of I:1000 (EC27-7351), 
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1:10000 (EC27-11209), 1:5000 (ORF101), or at various concentrations for Santa Cruz 
primary antibodies and incubated at 4'C for 2 hours to overnight. Membranes were 
washed 3 times in TTBS (150 mM NaC1, 10 mM Tris pH 7. 5, 0. 1'/o Tween-20) and then 
incubated in secondary antibody (horseradish peroxidase linked anti-rabbit or anti-mouse 
IgG, I:15000 in TTBS-Blotto, Santa Cruz Biotecbnology) for I hour at room 
temperature. Membranes were washed 3 times in TTBS and once in TBS (150 mM 
NaCI, 10 mM Tris pH 7. 5) and reacted I minute with chemiluminescence reagent 
(Renaissance, NEN) and exposed to film. Molecular weights were determined using 
pre-stained or unstained SDS-PAGE low range MW markers (Sigma). Bands were 
quantitated by Spot Denso function of the Chemimager Software package. 
SUMMARY 
We have characterized the baculovirus nucleocapsid protein and putative multifunctional 
viral cyclin EC27 through a series of genetic and biochemical methods. EC27 fails to 
rescue CLN (Gl cyclin) deficient S. cerevisiae as evidenced by a yeast complementation 
assay. Using antisera that can distinguish between the 35 and 27-kilodalton forms of 
EC27, we demonstrated that ORF101, a viral nucleocapsid protein that contains an 
LXCXE motif, can associate with the 35-kD EC27 but not with 27-kD EC27. The 27- 
kD EC27 associated complex has a higher level of cyclin kinase activity against the in 
vitro substrate histone Hl than 35-kD EC27 associated complex in the buffer system 
used here; the latter complex may not have a significant level of kinase activity when 
compared to baseline signal intensity. These studies suggest that EC27 may not function 
like a traditional, or cellular, cyclin by dimerizing with and activating cdk's and that 
EC27 may form multiple complexes with different partners that contain different 
functionalities. 
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